Home › Sarcoma ng Malambot na Tisyu › Massachusetts › Boston

Pag-aaral pangklinika para sa Sarcoma ng Malambot na Tisyu sa Boston, MA

Isang pag-aaral para sa Sarcoma ng Malambot na Tisyu ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute., Boston

Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06641908

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05732831

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06644755

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT05711615

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Nagre-recruitPhase 2

Dana-Farber Cancer Institute - Oncology Department, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06760819

Serial MRI Scans During Radiation Therapy

Nagre-recruit

Brigham and Women Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04188535

Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention

Nagre-recruit

Boston Children's Hospital, Boston
Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 15 hanggang 39 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07662239

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06975293

Distance-Based Exercise to Preserve Function and Prevent Disability

Nagre-recruit

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07059884

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Hanggang edad 30 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06239272

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Nagre-recruitObservasyonal na pag-aaral

Brigham and Women's Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT07377747

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Nagre-recruitObservasyonal na pag-aaral

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT07675967

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Nagre-recruitPhase 1/2

Massachusetts General Hospital,, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116

Video Education With Result Dependent dIsclosure

Nagre-recruit

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT05225428

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Nagre-recruitPhase 1/2

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Brigham and Women's Hospital, Boston

Edad 12 hanggang 49 · Lahat ng kasarian · Na-update Peb 19, 2026 · NCT06709495

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT04370587

REtroperitoneal SArcoma Registry: an International Prospective Initiative

Nagre-recruitObservasyonal na pag-aaral

Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 12, 2019 · NCT03838718

Pag-aaral para sa Sarcoma ng Malambot na Tisyu sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.